<DOC>
	<DOC>NCT00252824</DOC>
	<brief_summary>The purpose of the study is to compare the efficacy of a flexible dose of Symbicort with conventional stepwise treatment according to asthma treatment guidelines in patients with persistent asthma</brief_summary>
	<brief_title>STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Diagnosis of asthma Â³ 3 months Prescribed daily use of glucocorticosteroids at a dose &gt; 320 mcg/ day for at least 3 months prior to Visit 1 Smoking history &gt; 10 packyears Asthma exacerbation requiring change in asthma treatment during the last 14 days prior to inclusion Any significant disease or disorder that my jeopardize the safety of the patient. Additional inclusion and exclusion criteria will be evaluated by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>